ABBV vs HALO
ABBV vs HALO — side by side. Price, change, valuation.
ABBV
AbbVie Inc.
$256.91−0.94%
NYQ
HALO
Halozyme Therapeutics, Inc.
$81.48−0.55%
NasdaqGS
| Metric | ABBV | HALO | Side by side |
|---|---|---|---|
| Last price | $256.91 | $81.48 | +175.43 |
| Day Δ % | -0.94 | -0.55 | −0.40pp |
| Market cap | not on file | not on file | not on file |
| P/E (trailing) | not on file | not on file | not on file |
| Implied move | not on file | not on file | not on file |
| Put/Call OI | not on file | not on file | not on file |
| Analyst target (mean) | not on file | not on file | not on file |
Descriptor deltas are comparative facts (higher / lower), not a recommendation. A metric absent for either company is shown as “not on file” — never filled with a placeholder.